The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor- β in Pregnancy Complicated by Placental Insufficiency

Biomed Res Int. 2017:2017:6904325. doi: 10.1155/2017/6904325. Epub 2017 Jun 15.

Abstract

Aim: The aim of the study was to evaluate the role of Interleukin-17 (IL-17), Interleukin-23 (IL-23), and transforming growth factor-β (TGF-β) in pregnancy complicated by placental insufficiency and in normal pregnancy.

Material and methods: The study comprised 34 patients with pregnancy complicated by fetal growth restriction (FGR) associated with preeclampsia (PE), as well as 35 healthy pregnant women. The concentrations of IL-17, IL-23, and TGF-β in sera from maternal peripheral blood were determined by an immunoenzymatic assay.

Results: There were higher concentrations of IL-17 in the study group when compared to the controls. In the group of patients with placental insufficiency, the levels of IL-17 positively correlated with systolic blood pressure (R = 0.42, p < 0.01). The study obtained comparable concentrations of IL-23 in both studied groups. The concentrations of TGF-β were significantly lower in pregnancy complicated by the insufficiency of placenta when compared to the controls.

Conclusions: It seems possible that the increased concentrations of IL-17 and the deficiency of TGF-β in pregnancy complicated by FGR and PE can be responsible for the activation of inflammatory response observed in PE cases.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Female
  • Humans
  • Interleukin-17 / blood*
  • Interleukin-23 / blood*
  • Placental Insufficiency / blood*
  • Pregnancy
  • Transforming Growth Factor beta / blood*

Substances

  • Interleukin-17
  • Interleukin-23
  • Transforming Growth Factor beta